Mi
Non verificato

Mirum Pharmaceuticals, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieMercato azionarioSalute
27/09/2026
Web e Social Network
Telefonia e Varie
Industria
Biotecnologia
HIV, AIDS e malattie autoimmuni
Salute
Farmaceutica
Medicina - Varie
Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta on September 28, 2026
1.00
14/09/2026
Salute
Biotecnologia
Scienza
Farmaceutica
Mercato azionario
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1.00
08/09/2026
Mercato del lavoro
Biotecnologia
Salute
Scienza
Farmaceutica
Mirum Pharmaceuticals Appoints Dr. Rob Myers as Chief Medical Officer
1.00
02/09/2026
Eventi
Web e Social Network
Salute
Biotecnologia
Scienza
Farmaceutica
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
1.00
11/08/2026
Finanza
Mercato azionario
Salute
Biotecnologia
Sanità
Scienza
Farmaceutica
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1.00
05/08/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Salute
Biotecnologia
Scienza
Farmaceutica
Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
1.00
29/07/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Salute
Biotecnologia
Sanità
Scienza
Farmaceutica
Mirum Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026
1.00
13/07/2026
Biotecnologia
Sanità
Farmaceutica
Salute
Mercato azionario
Finanza
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1.00
11/06/2026
Mercato azionario
Finanza
Biotecnologia
Farmaceutica
Salute
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1.00
30/05/2026
Eventi
Industria
Oncologia
Salute
Igiene alimentare
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0